2.04
Mainz Biomed N V Borsa (MYNZ) Ultime notizie
Mainz Biomed N.V. Stock Analysis and ForecastStrong return on assets - jammulinksnews.com
What drives Mainz Biomed N.V. stock priceUnprecedented market success - Autocar Professional
Does Mainz Biomed N.V. stock pay reliable dividendsFree Stock Market Return Analysis - jammulinksnews.com
Should I buy Mainz Biomed N.V. stock before earningsHigh-impact stock picks - jammulinksnews.com
Mainz Biomed, CARE announce collaboration agreement - TipRanks
Mainz Biomed Partners with CARE Diagnostica to Enhance Colorectal Cancer Screening in Germany - Nasdaq
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies - GlobeNewswire
Mainz Biomed Expands Early Cancer Detection Program to 19 German Health Insurers Through CARE Partnership - Stock Titan
When the Price of (MYNZ) Talks, People Listen - news.stocktradersdaily.com
What analysts say about Mainz Biomed N.V. stockConsistently profitable trades - jammulinksnews.com
Is Mainz Biomed N.V. a good long term investmentRapid growth trajectories - jammulinksnews.com
Why Mainz Biomed N.V. stock attracts strong analyst attentionFree Long-Term Wealth Growth Plan - beatles.ru
Mainz Biomed (NASDAQ:MYNZ) Trading Up 7% – Here’s Why - Defense World
Mainz Biomed Half Year 2025 Update: Accelerating FDA - GlobeNewswire
What makes Mainz Biomed N.V. stock price move sharplyFree Stock Market Expert Consultation - Newser
ARBI(arbipad) News and UpdatesProtected Capital Trading Plan - Newser
How Mainz Biomed N.V. stock performs during market volatilityFree Step-by-Step Investment Guide - Newser
Mainz Biomed reviews accomplishments for first half of 2025 - TipRanks
Mainz Biomed N.V. Announces Key Achievements and Corporate Update for First Half of 2025 - Nasdaq
Mainz Biomed's Dual Breakthrough: FDA Trial Progress and Revolutionary 95% Accurate Pancreatic Cancer Detection - Stock Titan
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants - 富途牛牛
Mainz Biomed (MYNZ) Secures State Funding for Pancreatic Cancer Project | MYNZ Stock News - GuruFocus
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test - FinancialContent
Mainz Biomed (MYNZ) to Release Quarterly Earnings on Tuesday - Defense World
Where are the Opportunities in (MYNZ) - news.stocktradersdaily.com
Mainz Biomed (NASDAQ:MYNZ) Trading Down 1.9% – Here’s What Happened - Defense World
(MYNZ) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Mainz Biomed (MYNZ) Advances PancAlert Project for Pancreatic Ca - GuruFocus
Mainz Biomed Initiates Feasibility Study Of PancAlert Blood Test For Pancreatic Cancer Detection - Nasdaq
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):